142 related articles for article (PubMed ID: 9696373)
1. Ventriculolumber perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)-methyl]-1-(2-chloroethyl-1-nitrosou rea hydrochloride for subarachnoid dissemination of gliomas.
Ushio Y; Kochi M; Kitamura I; Kuratsu J
J Neurooncol; 1998; 38(2-3):207-12. PubMed ID: 9696373
[TBL] [Abstract][Full Text] [Related]
2. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
6. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
7. ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.
Gwak HS; Youn SM; Kwon AH; Lee SH; Kim JH; Rhee CH
J Neurooncol; 2005 Nov; 75(2):173-80. PubMed ID: 16132508
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.
Choi IS; Lee SH; Kim TY; Bang JS; Paek SH; Kim S; Kim IH; Heo DS; Bang YJ; Kim DG; Jung HW; Kim NK
J Neurooncol; 2002 Nov; 60(2):171-6. PubMed ID: 12635665
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Beppu T; Yoshida Y; Arai H; Wada T; Suzuki M; Ogawa A; Hakozaki S; Kubo N
J Neurooncol; 2000 Sep; 49(3):213-8. PubMed ID: 11212900
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
[TBL] [Abstract][Full Text] [Related]
11. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
12. Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
Anders K; Grabenbauer GG; Schuchardt U; Fahlbusch R; Fietkau R; Sauer R; Krauseneck P
J Neurooncol; 2000 May; 48(1):63-73. PubMed ID: 11026699
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of DTIC, ACNU, and vincristine combination chemotherapy for supratentorial malignant astrocytomas.
Ikeda J; Aida T; Sawamura Y; Abe H; Kaneko S; Kashiwaba T; Kawamoto T; Mitsumori K; Saitoh H
Neurol Med Chir (Tokyo); 1996 Aug; 36(8):555-8; discussion 558-9. PubMed ID: 8831197
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy.
Vega F; Davila L; Chatellier G; Chiras J; Fauchon F; Cornu P; Capelle L; Poisson M; Delattre JY
J Neurooncol; 1992 Jun; 13(2):131-5. PubMed ID: 1331343
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
Shibui S; Narita Y; Mizusawa J; Beppu T; Ogasawara K; Sawamura Y; Kobayashi H; Nishikawa R; Mishima K; Muragaki Y; Maruyama T; Kuratsu J; Nakamura H; Kochi M; Minamida Y; Yamaki T; Kumabe T; Tominaga T; Kayama T; Sakurada K; Nagane M; Kobayashi K; Nakamura H; Ito T; Yazaki T; Sasaki H; Tanaka K; Takahashi H; Asai A; Todo T; Wakabayashi T; Takahashi J; Takano S; Fujimaki T; Sumi M; Miyakita Y; Nakazato Y; Sato A; Fukuda H; Nomura K
Cancer Chemother Pharmacol; 2013 Feb; 71(2):511-21. PubMed ID: 23228988
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma.
Hirano Y; Mineura K; Mizoi K; Tomura N
Int J Oncol; 1998 Sep; 13(3):537-42. PubMed ID: 9683790
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial ACNU and cisplatin chemotherapy for the treatment of glioblastoma multiforme.
Iwadate Y; Namba H; Sueyoshi K
Neurol Med Chir (Tokyo); 1995 Aug; 35(8):598-603. PubMed ID: 7566393
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Düsseldorf University.
Roosen N; Kiwit JC; Lins E; Schirmer M; Bock WJ
Cancer; 1989 Nov; 64(10):1984-94. PubMed ID: 2553234
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
